UK markets closed

Aprea Therapeutics, Inc. (APRE)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
5.35+0.07 (+1.33%)
At close: 04:00PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts2222
Avg. Estimate-0.78-0.81-2.38-0.96
Low estimate-0.8-0.81-3.36-1.34
High estimate-0.75-0.8-1.39-0.58
Year ago EPS-1.34-0.87-3.95-2.38
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts2222
Avg. EstimateN/AN/A300k300k
Low estimateN/AN/AN/AN/A
High estimateN/AN/A600k600k
Year ago salesN/A250k583k300k
Sales growth (year/est)N/AN/A-48.50%0.00%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-1.5-1.42-1.16-0.77
Actual EPS-1.34-0.87-0.86-0.92
Difference0.160.550.3-0.15
Surprise %10.70%38.70%25.90%-19.50%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-0.78-0.81-2.38-0.96
7 days ago-0.78-0.81-2.38-0.96
30 days ago-0.78-0.81-2.38-0.96
60 days ago-0.2-0.22-2.24-1.85
90 days ago-0.2-0.22-2.24-1.85
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesAPREIndustrySector(s)S&P 500
Current qtr.41.80%N/AN/AN/A
Next qtr.6.90%N/AN/AN/A
Current year39.70%N/AN/AN/A
Next year59.70%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A